Mourad O, Palda V, Detsky AS. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med. 2003;163(5):545-551.
Arnow PM, Flaherty JP. Fever of unknown origin. Lancet. 1997;350(9077):575-580.
Nazar AH, Naswa N, Sharma P, et al.; Spectrum of 18F-FDG PET/CT findings in patients presenting with fever of unknown origin. AJR Am J Roentgenol. 2012;199(1):175-185.
Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Intern Med. 2003;253(3):263-275.
Hayakawa K, Ramasamy B, Chandrasekar PH. Fever of unknown origin: an evidence-based review. Am J Med Sci. 2012;344(4):307-316.
Hersch EC, Oh RC. Prolonged febrile illness and fever of unknown origin in adults. Am Fam Physician. 2014;90(2):91-96. Accessed August 18, 2021. https://www.aafp.org/afp/2014/0715/p91.html
Beresford RW, Gosbell IB. Pyrexia of unknown origin: causes, investigation and management. Intern Med J. 2016;46(9):1011-1016.
Cunha BA, Lortholary O, Cunha CB. Fever of unknown origin: a clinical approach. Am J Med. 2015;128(10):1138.e1-1138.e15.
Manappallil R, Manuel R, Shalu S, et al.; Fever of unknown origin: a dental aetiology. Int J Med Sci Clin Invent. 2016;3(12):2424-2426.
Aduan RP, Fauci AS, Dale DC, et al.; Factitious fever and self-induced infection: a report of 32 cases and review of the literature. Ann Intern Med. 1979;90(2):230-242.
Bleeker-Rovers CP, Vos FJ, de Kleijn EMHA, et al.; A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore). 2007;86(1):26-38.
de Kleijn EMHA, Vandenbroucke JP, van der Meer JWM; Netherlands FUO Study Group; Fever of unknown origin (FUO). I. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. Medicine (Baltimore). 1997;76(6):392-400.
Cunha BA. Fever of unknown origin: focused diagnostic approach based on clinical clues from the history, physical examination, and laboratory tests. Infect Dis Clin North Am. 2007;21(4):1137-1187.
Limper M, de Kruif MD, Duits AJ, et al.; The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect. 2010;60(6):409-416.
van der Geest KSM, Sandovici M, Brouwer E, et al.; Diagnostic accuracy of symptoms, physical signs, and laboratory tests for giant cell arteritis: a systematic review and meta-analysis. JAMA Intern Med. 2020;180(10):1295-1304.
Durnaś B, Wątek M, Wollny T, et al.; Utility of blood procalcitonin concentration in the management of cancer patients with infections. Onco Targets Ther. 2016;9:469-475.
Wright WF, Auwaerter PG. Fever and fever of unknown origin: review, recent advances, and lingering dogma. Open Forum Infect Dis. 2020;7(5):ofaa132.
Wong CY, Zhu W, Aurigemma GP, et al.; Infective endocarditis among persons aged 18–64 years living with human immunodeficiency virus, hepatitis C infection, or opioid use disorder, United States, 2007–2017. Clin Infect Dis. 2021;72(10):1767-1781.
Cunha BA. Fever of unknown origin: clinical overview of classic and current concepts [published correction appears in Infect Dis Clin North Am. 2008; 22(2): xv]. Infect Dis Clin North Am. 2007;21(4):867-915.
Schönau V, Vogel K, Englbrecht M, et al.; The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study. Ann Rheum Dis. 2018;77(1):70-77.
Fautrel B, Le Moël G, Saint-Marcoux B, et al.; Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol. 2001;28(2):322-329.
Cantini F, Salvarani C, Olivieri I, et al.; Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum. 2000;30(1):17-24.
Soto-Gomez N, Peters JI, Nambiar AM. Diagnosis and management of sarcoidosis. Am Fam Physician. 2016;93(10):840-848. Accessed August 31, 2021. https://www.aafp.org/afp/2016/0515/p840.html
Raman SP, Horton KM, Fishman EK. Computed tomography of Crohn's disease: the role of three dimensional technique. World J Radiol. 2013;5(5):193-201.
Aburahma AF, Saiedy S. Deep vein thrombosis as probable cause of fever of unknown origin. W V Med J. 1997;93(1):368-370.
Kane SV, Sandborn WJ, Rufo PA, et al.; Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003;98(6):1309-1314.
Georga S, Exadaktylou P, Petrou I, et al.; Diagnostic value of 18F-FDG-PET/CT in patients with FUO. J Clin Med. 2020;9(7):2112-2131.
Tavakoli AA, Reichert M, Blank T, et al.; Findings in whole body MRI and conventional imaging in patients with fever of unknown origin—a retrospective study. BMC Med Imaging. 2020;20(1):94-100.
Kouijzer IJE, Mulders-Manders CM, Bleeker-Rovers CP, et al.; Fever of unknown origin: the value of FDG-PET/CT. Semin Nucl Med. 2018;48(2):100-107.
Hot A, Jaisson I, Girard C, et al.; Yield of bone marrow examination in diagnosing the source of fever of unknown origin. Arch Intern Med. 2009;169(21):2018-2023.
Mulders-Manders C, Simon A, Bleeker-Rovers C. Fever of unknown origin. Clin Med (Lond). 2015;15(3):280-284.
Ben-Baruch S, Canaani J, Braunstein R, et al.; Predictive parameters for a diagnostic bone marrow biopsy specimen in the work-up of fever of unknown origin. Mayo Clin Proc. 2012;87(2):136-142.
de Kleijn EM, van Lier HJ, van der Meer JW; Netherlands FUO Study Group; Fever of unknown origin (FUO). II. Diagnostic procedures in a prospective multicenter study of 167 patients. Medicine (Baltimore). 1997;76(6):401-414.
Quesada AE, Tholpady A, Wanger A, et al.; Utility of bone marrow examination for workup of fever of unknown origin in patients with HIV/AIDS [published corrections appear in J Clin Pathol. 2015;68(7):577 and J Clin Pathol. 2015;68(6):487]. J Clin Pathol. 2015;68(3):241-245.
Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore). 1961;40:1-30.
Holtz T, Moseley RH, Scheiman JM. Liver biopsy in fever of unknown origin. A reappraisal. J Clin Gastroenterol. 1993;17(1):29-32.
Arch-Ferrer JE, Velázquez-Fernández D, Sierra-Madero J, et al.; Laparoscopic approach to fever of unknown origin. Surg Endosc. 2003;17(3):494-497.
Mulders-Manders CM, Engwerda C, Simon A, et al.; Long-term prognosis, treatment, and outcome of patients with fever of unknown origin in whom no diagnosis was made despite extensive investigation: a questionnaire based study. Medicine (Baltimore). 2018;97(25):e11241.
Durack DT, Street AC. Fever of unknown origin — reexamined and redefined. Curr Clin Top Infect Dis. 1991;11:35-51.
Freifeld AG, Bow EJ, Sepkowitz KA, et al; Infectious Diseases Society of America; Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):e56-e93.
Roth AR, Basello GM. Approach to the adult patient with fever of unknown origin. Am Fam Physician. 2003;68(11):2223-2229. Accessed August 18, 2021. https://www.aafp.org/afp/2003/1201/p2223.html